Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01683812
Other study ID # IRB-P00003465
Secondary ID
Status Completed
Phase N/A
First received August 29, 2012
Last updated December 8, 2016
Start date May 2012
Est. completion date June 2013

Study information

Verified date December 2016
Source Boston Children’s Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this descriptive study is to provide information on the feasibility of using the cranial cup, a new positioning device, in a small sample of prematurely born infants with elongated head shapes as a result of laying on their abdomens, during the convalescent phase of their hospitalizations.


Description:

The cranial cup is a non-invasive, non-restrictive, adjustable orthotic device that grows with the infant and maintains proper body alignment while promoting normal head shape development. While the cranial cup is not yet FDA approved, it is considered a non-significant medical device and it has successfully corrected asymmetric positional head shape deformities in hundreds of healthy newborns less than 4 months of age cared for by the Children's Hospital Boston outpatient plagiocephaly clinic. Additionally preliminary analysis of a prospective randomized controlled trial currently underway suggests that the cranial cup may be useful in prevention of positional head shape deformity in a cohort of hospitalized infants of varying gestational ages. However, the cranial cup has never been used for correction of the most common form of positional head shape deformity in hospitalized premature infants; namely dolichocephaly. Thus, the purpose of this descriptive study is to provide information on the feasibility of using the cranial cup in a small sample of prematurely born infants with dolichocephaly during the convalescent phase of their hospitalizations. Information obtained from this descriptive study will be used to determine if a larger investigation using the cranial cup is warranted in this specific patient population.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group N/A to 1 Year
Eligibility Inclusion Criteria:

- Born at < or equal to 35 weeks gestation

- Cleared for participation by healthcare team

- Estimated minimum length of stay >14 days

- Weight >1000 grams (at enrollment)

- Dolichocephalic head shape deformity

Exclusion Criteria:

- Unable to maintain airway patency (anatomical problem)

- Craniofacial anomaly or scalp device, drain or shunt

- Craniosynostosis

- Severe parturitional head shape deformity

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Cranial Cup
Study participants with dolichocephaly will be treated with the Cranial Cup for a minimum 12 hours per day.

Locations

Country Name City State
United States Boston Children's Hospital Boston Massachusetts
United States Winchester Hospital Winchester Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Boston Children’s Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility and Safety Nurses will complete daily logs indicating the number of desaturation events and emesis events during cranial cup device use. The cup's designated use is for at least 12 hours per day. Study duration is at least 14 days and can continue until the infant is discharged. Comparisons will be made for the number of desaturation events and emesis during data analysis. Logs of cranial cup use and desaturation and emesis events will be recorded for 14 -120 days Yes
Secondary Head shape measurement description To describe infant head shape, the study will use cranial measurements and laser head scans in a sample of prematurely born NICU or SCN patients with dolichocephaly. Measurements and scans will be taken directly following study enrollment and discharge to document head shape pre and post intervention. The discharge measure will be obtained at approximately 2 weeks-4 months of age at hospital discharge. Using head measurements obtained at timepoint 1 (enrollment) and at discharge (14-120 days) No
See also
  Status Clinical Trial Phase
Completed NCT02366936 - Treatment of Cranial Molding Deformities in Preterm Infants N/A